Child-oriented Goal-setting for Neurodevelopmental Disorders
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new approach called ENGAGE, which helps children with neurodevelopmental disabilities set and achieve personal goals during therapy. The aim is to see if involving children more in goal-setting improves their therapy outcomes and quality of life.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications. It is best to consult with the trial coordinators for specific guidance.
Is the child-oriented goal-setting treatment for neurodevelopmental disorders safe for children?
The research articles do not provide specific safety data for the child-oriented goal-setting treatment or its variations like ENGAGE. However, general pediatric drug safety surveillance shows that adverse events are monitored and reported, which helps in understanding and managing risks in treatments for children.12345
How does the ENGAGE treatment differ from other treatments for neurodevelopmental disorders?
What data supports the effectiveness of the treatment ENGAGE for neurodevelopmental disorders?
The research highlights the importance of involving children and families in setting goals for treatment, which is a key part of the ENGAGE approach. This collaborative goal-setting has been shown to be effective in other areas, like rehabilitation for brain injuries, suggesting it could also be beneficial for neurodevelopmental disorders.611121314
Who Is on the Research Team?
Lesley Pritchard, PhD
Principal Investigator
University of Alberta
Sandra Hodgetts, PhD
Principal Investigator
University of Alberta
Are You a Good Fit for This Trial?
This trial is for English-speaking children aged 5-12 with neurodevelopmental disabilities who are referred to Physical or Occupational Therapy. It's not suitable for kids with progressive conditions or uncontrolled seizures (having had a seizure in the last 2 months).Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Children participate in the ENGAGE approach to goal setting or usual practice based on the allocation of their therapist. Treatment block lengths vary from 3-8 sessions over 2-8 weeks.
Post-treatment Assessment
Assessments are conducted to evaluate changes in goal-related performance, functional abilities, and quality of life.
Follow-up
Participants are monitored for sustained effects on goal-related performance, functional abilities, and quality of life.
What Are the Treatments Tested in This Trial?
Interventions
- ENGAGE
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alberta
Lead Sponsor
Alberta Health services
Collaborator